FDA Brief

Warning letters Drugs

FDA warning letter to

SemaBio

LowIssued Sep 9, 2025Posted Sep 16, 2025Center for Drug Evaluation and Research (CDER)

FDA warned SemaBio that its website sold compounded semaglutide and called it 'generic semaglutide,' a false or misleading claim.

What happened

FDA reviewed SemaBio's website at https://sema.bio in August 2025. FDA found the site offered compounded drug products, including semaglutide, and repeatedly used the claim 'generic semaglutide.' FDA says that claim is false or misleading because compounded drugs are not FDA-approved and the wording implies they are the same as an approved product.

What FDA found

  1. The website repeatedly called compounded semaglutide 'generic semaglutide,' which falsely implies it is the same as an FDA-approved product.

    FDCA sections 502(a) and 502(bb) [21 U.S.C. §§ 352(a), 352(bb)]
  2. Because of that claim, FDA says the compounded semaglutide products are misbranded drugs.

    FDCA sections 502(a) and 502(bb) [21 U.S.C. §§ 352(a), 352(bb)]
  3. FDA says the misbranded products were introduced or delivered for introduction into interstate commerce.

    FDCA section 301(a) [21 U.S.C. § 331(a)]
  4. FDA also says receiving misbranded drugs in interstate commerce, and delivering or offering to deliver them, is a violation.

    FDCA section 301(c) [21 U.S.C. § 331(c)]

What FDA wants

FDA tells SemaBio to take immediate action, including stopping the misleading 'generic semaglutide' language, and to send a written response within 15 working days describing steps taken, how recurrence will be prevented, and related documentation.

Who should pay attention

  • telehealth companies selling compounded semaglutide
  • online pharmacies and compounding pharmacies
  • marketing and compliance teams for drug websites

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low